Liquidity Services (NASDAQ: LQDT), a global solution provider in the reverse supply chain with the world's largest marketplace for business surplus, is pleased to present this month's featured auctions for biopharmaceutical/healthcare assets in Europe and North America. The auctions will be held on GoIndustry DoveBid, a Liquidity Services online marketplace where more than $450 million in biopharmaceutical assets from small, medium-size and Fortune 1,000 companies have been sold to an audience of registered industry buyers across the globe.

Upcoming sales include:

BioPharma #561148, an eight-day event that is part of GoIndustry DoveBid's regular auction series, BioPharma Equipment Marketplace. The sale closes at 9 a.m. EDT on July 13, 2016 and features more than 700 assets, many in immaculate condition, from Europe's top biopharmaceutical/healthcare companies. Specific items up for bid include a PARKER Balston HRPEM-260 hydrogen generator and a Perkin Elmer Model 480 DNA thermal cycler.

BioPharma #501443 is a three-day sale that begins at 12 a.m. EDT on July 11, 2016 and closes at 5 p.m. EDT on July 13, 2016. The event features more than 30 assets from four major pharmaceutical companies with facilities located in California, Illinois, Ohio and New Jersey. A variety of good condition, five to 10 year old equipment previously used in research and development activities is for sale, including a Modern Packaging automatic filling and sealing machine and a ThermoFisher Scientific Forma™ Series II 3110 Water-Jacketed CO 2 Incubator.

BioPharma #561183 starts at 9 a.m. EDT on July 13, 2016 and ends at 9 a.m. EDT on July 20, 2016. More than 200 assets from a global biopharmaceutical company's facility in Cheshire, U.K. are for sale, including a Heraeus™ Labofuge™ 200 Centrifuge and a CoaguCheck Plus monitor.

BioPharma #501444, a three-day event that starts at 12 a.m. EDT on July 18, 2016 and ends at 5 p.m. EDT on July 20, 2016. The auction features the sale of more than 100 assets from the Kenilworth, NJ campuses of two global biopharmaceutical companies. Assets include good condition equipment previously used in product research, development and manufacturing operations including a Siemens BCS® automated hemostasis analyzer and a Bio-Rad iCycler thermal cycler.

"The biopharmaceutical industry is fiercely competitive," said Gardner Dudley, President of Liquidity Services' Capital Assets Group. "Companies seek to maintain their competitive edge through innovative research and development programs and expansion into new global markets. To help fund these expensive initiatives, they are partnering with Liquidity Services to sell their idle or surplus assets, recouping valuable dollars from previous capital expenditures."

To place bids on items for sale in this auction, or to participate in any auction on a Liquidity Services marketplace, visit

View source version on

Copyright Business Wire 2010